Bulk Pharmaceutical API Sources for TOFRANIL-PM

Bulk Pharmaceutical API Sources for TOFRANIL-PM

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		24904
ABI Chem		AC1L2NRC
Clearsynth		CS-P-06966
Smolecule		S597302
THE BioTek		bt-372134

Bulk Active Pharmaceutical Ingredient (API) Sources for TOFRANIL-PM

Last updated: July 29, 2025

Introduction

TOFRANIL-PM, marketed as Clomipramine Hydrochloride, is a tricyclic antidepressant primarily prescribed for obsessive-compulsive disorder (OCD), major depressive disorder, and other psychiatric conditions. Its efficacy hinges on the purity and stability of its active pharmaceutical ingredient (API). As demand for psycho-pharmaceuticals increases, sourcing high-quality API becomes paramount for pharmaceutical companies to ensure product efficacy, regulatory compliance, and cost efficiency.

This article examines the global landscape of suppliers providing bulk Clomipramine Hydrochloride, evaluating their manufacturing capabilities, quality standards, regulatory compliance, and strategic positioning essential for sourcing considerations.

---

Overview of Clomipramine Hydrochloride API

Clomipramine Hydrochloride is a potent tricyclic antidepressant. The API’s synthesis involves complex multi-step processes demanding stringent quality controls to meet pharmacopeia standards. The application spectrum necessitates high API purity (>99%), consistent batch-to-batch reproducibility, and adherence to GMP guidelines ([3]).

---

Global API Manufacturers for Clomipramine Hydrochloride

The landscape of Clomipramine Hydrochloride API manufacturing comprises established pharmaceutical ingredient producers, contract manufacturing organizations (CMOs), and APIs sourced from emerging generic drug producers in Asia. The following sections analyze key suppliers, their regulatory status, manufacturing locations, and strategic advantages.

1. Major Multinational API Suppliers

a. Novartis / Sandoz

Historically, Novartis and its division Sandoz have been involved in producing various tricyclic antidepressants, including Clomipramine. Their manufacturing facilities in Europe and North America uphold strict GMP standards, ensuring high-quality APIs suitable for global markets.

• Strengths: High compliance with international regulatory standards, rigorous quality control, and reliable supply chain management.

• Limitations: Due to their focus on branded pharmaceuticals, supply volume for bulk APIs may be limited or primarily directed towards proprietary formulations.

b. Teva Pharmaceutical Industries

Teva operates manufacturing sites in Israel and Europe with extensive experience producing CNS-active APIs. Their capabilities include large-scale synthesis of tricyclic compounds with high purity requirements.

• Strengths: Established quality management systems, comprehensive regulatory approvals, and strong global distribution.

• Limitations: Potentially higher costs relative to Asian producers; procurement negotiations may be complex.

2. Asian API Manufacturers

Asian manufacturers, especially from China and India, dominate the global API supply for generic pharmaceuticals. Their cost advantage and scalable production have made them primary sources for Clomipramine Hydrochloride.

a. Zhejiang Kanglong Pharmaceutical Co., Ltd. (China)

A leading Chinese API producer specializing in antidepressants, including Clomipramine Hydrochloride, with multiple GMP certifications.

• Regulatory Status: Approved by Chinese authorities; some APIs have gained certifications aligning with European cGMP standards.

• Advantages: Competitive pricing, flexible batch sizes, and reliable supply.

b. Zhejiang Huahai Pharmaceutical Co., Ltd. (China)

A major manufacturer with extensive experience in CNS APIs. Their facilities comply with several international standards, and their APIs are widely used in generic formulations globally.

• Quality Assurance: Emphasis on rigorous quality testing and compliance with pharmacopeias (USP, EP, JP).

• Market Reach: Supplies to numerous generic pharmaceutical firms worldwide.

c. Granules India Ltd. (India)

Known for producing high-quality APIs and bulk drugs, including Clomipramine Hydrochloride, with dedicated R&D and quality systems.

• Certifications: US FDA, EMA, and WHO GMP approved facilities.

• Supply Capabilities: Large-scale manufacturing with consistent quality and competitive pricing.

3. Contract Manufacturing Organizations (CMOs)

CMOs offer flexible production options, larger capacity, and expertise in complex APIs like Clomipramine Hydrochloride.

a. Dishman Carbogen Amcis (India/Switzerland)

Offers custom API synthesis, including complex tricyclic compounds, with a focus on GMP compliance for international markets.

b. Cambrex Corporation

Based in the USA, Cambrex provides large-scale batch manufacturing, process development, and quality assurance tailored for APIs with high regulatory standards.

---

Regulatory and Quality Considerations

Ensuring API quality is critical, especially for CNS drugs like TOFRANIL-PM. Sourcing from GMP-certified manufacturers, with high-quality batch documentation and stability data, mitigates regulatory compliance risks.

• GMP Certification: Essential for bulk API suppliers to supply to regulated markets.

• Third-party Testing: Confirm batches are tested according to pharmacopeial monographs (USP, EP, JP).

• Regulatory Approvals: Suppliers with FDA/EMA approvals ensure broader market eligibility.

---

Strategic Sourcing Factors

• Cost Efficiency: Asian manufacturers often offer competitive pricing but verify quality standards.

• Supply Reliability: Long-standing relationship with established manufacturers reduces supply chain disruptions.

• Quality Certifications: Prioritize suppliers with recognized GMP adherence and quality audits.

• Regulatory Documentation: Adequate dossiers, MSDS, batch records, and stability data facilitate approval processes.

• Geopolitical Considerations: Political stability and trade agreements influence sourcing decisions.

---

Challenges and Considerations

• Quality Assurance Variability: Not all manufacturers maintain equally rigorous standards; comprehensive audits and validations are essential.

• Regulatory Compliance: APIs from non-approved sites may delay drug approval or market entry.

• Intellectual Property: Manufacturing processes should not infringe on proprietary methods.

• Traceability: Transparent supply chains mitigate risks of counterfeit or substandard APIs.

---

Conclusion

The global landscape offers a broad spectrum of sources for bulk Clomipramine Hydrochloride API suitable for TOFRANIL-PM production. While multinational companies like Novartis and Teva provide high regulatory assurance, Asian manufacturers such as Zhejiang Kanglong, Huahai, and Granules India offer cost-effective alternatives with high-quality standards.

Strategic procurement should emphasize regulatory compliance, consistent quality, supply reliability, and competitive pricing. Engaging with reputable suppliers and conducting rigorous audits are vital steps to mitigate risks associated with API sourcing.

---

Key Takeaways

• The API for TOFRANIL-PM, Clomipramine Hydrochloride, is supplied by a mix of global pharma giants and Asian generic manufacturers.
• Asian suppliers dominate in cost-effectiveness, but thorough regulatory due diligence is crucial.
• GMP certification, quality assurance, and regulatory approvals are non-negotiable criteria.
• Contract manufacturers offer scalable production but require validation of quality systems.
• Strategic sourcing should balance cost with compliance, reliability, and geopolitical considerations to ensure uninterrupted supply.

---

FAQs

1. What are the primary regions supplying Clomipramine Hydrochloride APIs globally?
Asia (China and India) dominate as primary suppliers due to cost advantages, while Europe and North America supply through multinational firms emphasizing regulatory compliance.

2. How do I ensure the quality of API from Asian manufacturers?
Verify GMP certifications, conduct supplier audits, request quality documentation, and review third-party testing analyses to confirm API purity and compliance.

3. Are Asian API manufacturers compliant with international regulations?
Many Asian manufacturers are certified with WHO GMP, US FDA, and EMA approvals, but due diligence is essential to confirm specific API batches meet regulatory standards.

4. What factors influence the choice between multinational and Asian API suppliers?
Cost, regulatory compliance, supply stability, quality standards, and geopolitical considerations heavily influence sourcing decisions.

5. Can APIs from different sources be used interchangeably in manufacturing TOFRANIL-PM?
While chemically identical, variability in purity, process residues, and excipients necessitates validation and comparability studies before substituting APIs from different sources.

---

References

[1] U.S. Pharmacopeia, Clomipramine Hydrochloride Monograph.
[2] European Pharmacopoeia, Clomipramine Hydrochloride.
[3] "Manufacturing and Quality Control of Antidepressants," Journal of Pharmaceutical Sciences.
[4] FDA Drug Master Files for Clomipramine Hydrochloride APIs.
[5] "Global API Market Trends," IQVIA Report, 2022.